ArticleBMJ open2026

Feasibility of a randomised controlled trial comparing opioid dose escalation with low-dose methadone addition for refractory cancer pain: JORTC-PAL23/NCCH2309 - protocol.

Takako Ikegami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.